Table 1 Demographic characteristics and baseline scoring in the short-form McGill Pain Questionnaire of patients with neuropathic pain or neuropathic and nociceptive mixed pain observed in the study.
Variable | FMS (n = 46) | NeP (n = 92) | MP (n = 92) | p |
|---|---|---|---|---|
Age (years) | 50.8 (47.8-53.8) | 50.9 (48.8-53.0) | 50.7 (48.6-52.8) | 0.989 (F = 0.01; df = 229) |
Sex, female (%) | 85 [71 - 94] | 85 [76 - 91] | 85 [76 - 91] | 1.000 (X2 = 0.002; df = 2) |
Time since diagnosis (years) | 1.8 (1.3-2.3) | 1.4 (0.7-2.1) | 1.9 (1.2-2.6) | 0.434 (F = 0.69; df = 229) |
0 - 12 months (%) | 52 [37 - 67] | 75 [65 - 83] | 61 [50 - 71] | 0 |
12 - 24 months (%) | 15 [6 - 29] | 10 [5 - 18] | 11 [5 - 19] | 0 |
> 24 months (%) | 33 [20 - 48] | 15 [9 - 24] | 28 [19 - 39] | 0 |
Previous analgesic treatment (%) | 30 [187-46] | 65 [59-79] | 67 [57-77] | 0.001 (X2 = 19.68; df = 2) |
Pain score (McGill) | ||||
VAS (0 to 100): | 70.8 (66.2-75.4) | 71.7 (67.5-75.9) | 72.6 (69.1-70.1) | 0.849 (F = 0.16; df = 229) |
PPI (0 to 5): | 2.6 (2.3-2.9) | 2.7 (2.5-3.0) | 2.9 (2.7-3.0) | 0.294 (F = 1.23; df = 229) |
Self-perceived symptoms of; | ||||
Anxiety (COVI; 0-15) | 7.0 (6.2-7.9) | 5.8 (5.2-6.4) | 5.8 (5.2-6.3) | 0.028 (F = 3.65; df = 229) |
Depression (RASKIN; 0-15) | 8.4 (7.4-9.4) | 6.4 (5.7-7.1) | 6.5 (5.9-7.1) | 0.001 (F = 7.39; df = 229) |